# AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration

> **NCT04263181** · — · ACTIVE_NOT_RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 80 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndromes

## Interventions

- **PROCEDURE:** Peripheral blood draw
- **PROCEDURE:** Bone marrow aspirate
- **PROCEDURE:** Buccal swab

## Key facts

- **NCT ID:** NCT04263181
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-29
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2026-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04263181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04263181, "AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04263181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*